Chime Financial, Inc. CHYM
CHYM among the 273 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
CHYM and 9 peers, year by year
The 9 Financials companies closest to CHYM in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| CHYM Chime Financial, Inc. | FY2025 | $2.2B | +30.7% | 88.0% | −47.6% | −46.2% | 1.5% | −72.1% | - |
| MORN Morningstar, Inc. | FY2025 | $2.4B | +7.5% | - | 21.5% | 15.3% | 18.1% | 30.6% | 0.88 |
| JKHY Jack Henry & Associates | FY2026 | $2.5B | +7.1% | - | 25.0% | 19.8% | 27.3% | 24.5% | 0.02 |
| SSB SouthState Bank Corp | FY2025 | $2.7B | +56.1% | - | - | 29.8% | 8.6% | 8.8% | - |
| HLI Houlihan Lokey, Inc. | FY2026 | $2.6B | +9.5% | - | 20.1% | 16.3% | 26.0% | 18.2% | - |
| SEIC SEI Investments Co | FY2025 | $2.3B | +8.1% | 35.2% | 27.3% | 31.1% | 25.5% | 29.2% | 0.00 |
| COLB Columbia Banking System, Inc. | FY2025 | $2.3B | +18.8% | - | - | 23.9% | - | 7.0% | - |
| FDS FactSet | FY2026 | $2.5B | +6.7% | - | 28.3% | 21.5% | 28.6% | 26.6% | 0.68 |
| ONB OLD National Bancorp | FY2025 | $2.5B | +33.9% | - | - | 26.5% | 25.2% | 7.9% | - |
| FRHC Freedom Holding Corp. | FY2026 | $2.2B | +9.3% | - | - | 7.0% | −0.6% | 10.3% | - |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2023 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2023 to FY2025
Revenue as reported in the 10-K.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| CHYM Dec | $1.3B | $1.7B | $2.2B |
| MORN Dec | $2.0B | $2.3B | $2.4B |
| JKHY Jun | $2.1B | $2.2B | $2.4B |
| SSB Dec | $1.7B | $1.7B | $2.7B |
| HLI Mar | $1.8B | $1.9B | $2.4B |
| SEIC Dec | $1.9B | $2.1B | $2.3B |
| COLB Dec | $2.0B | $1.9B | $2.3B |
| FDS Aug | $2.1B | $2.2B | $2.3B |
| ONB Dec | $1.8B | $1.9B | $2.5B |
| FRHC Mar | $799.1M | $1.6B | $2.0B |
| Peer median | $1.9B | $1.9B | $2.4B |
Sales growth, FY2023 to FY2025
Revenue against the fiscal year before.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| CHYM Dec | - | +30.9% | +30.7% |
| MORN Dec | +9.0% | +11.6% | +7.5% |
| JKHY Jun | +6.9% | +6.6% | +7.2% |
| SSB Dec | +5.8% | −1.3% | +56.1% |
| HLI Mar | −20.3% | +5.8% | +24.8% |
| SEIC Dec | −3.6% | +10.7% | +8.1% |
| COLB Dec | +56.4% | +11.2% | +18.8% |
| FDS Aug | +13.1% | +5.6% | +5.4% |
| ONB Dec | +6.3% | +2.7% | +33.9% |
| FRHC Mar | +15.4% | +109% | +21.7% |
| Peer median | +6.9% | +6.6% | +18.8% |
Gross margin, FY2023 to FY2025
Gross profit / revenue.
Operating margin, FY2023 to FY2025
Operating income / revenue.
Net margin, FY2023 to FY2025
Net income / revenue.
Free cash flow, FY2023 to FY2025
Cash from operations minus capital spending.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| CHYM Dec | −$167.1M | $59.3M | $32.9M |
| MORN Dec | $197.3M | $448.9M | $442.6M |
| JKHY Jun | $342.4M | $509.9M | $588.1M |
| SSB Dec | $507.9M | $476.2M | $230.6M |
| HLI Mar | $85.5M | $261.7M | $808.9M |
| SEIC Dec | $422.2M | $590.1M | $585.0M |
| COLB Dec | - | - | - |
| FDS Aug | $584.8M | $614.7M | $617.5M |
| ONB Dec | $478.0M | $592.0M | $637.4M |
| FRHC Mar | −$990.2M | −$1.1B | $1.6B |
| Peer median | $382.3M | $493.0M | $602.8M |
FCF margin, FY2023 to FY2025
Free cash flow / revenue.
Return on equity, FY2023 to FY2025
Net income / shareholders' equity at the year end.
Debt / equity, FY2023 to FY2025
Total debt / shareholders' equity at the year end.
EPS (diluted), FY2023 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| CHYM Dec | −$3.22 | −$0.39 | −$4.27 |
| MORN Dec | $3.29 | $8.58 | $8.87 |
| JKHY Jun | $5.02 | $5.23 | $6.24 |
| SSB Dec | $6.46 | $6.97 | $7.87 |
| HLI Mar | $3.76 | $4.11 | $5.82 |
| SEIC Dec | $3.46 | $4.41 | $5.63 |
| COLB Dec | $1.78 | $2.55 | $2.30 |
| FDS Aug | $12.04 | $13.91 | $15.55 |
| ONB Dec | $1.94 | $1.68 | $1.79 |
| FRHC Mar | $3.45 | $6.39 | $1.26 |
| Peer median | $3.46 | $5.23 | $5.82 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out CHYM and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: CHYM's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHYM/export.csv") into a cell.